Malaria in Pregnancy

Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics

Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

LAMP Detection of Malaria in PREGnancy (LAMPREG) Trial

Plasmodium Falciparum Genomic Intelligence in Mozambique

Malaria Molecular Surveillance in Mozambique (Phase 2)

Follow-up of Immunological Pattern and Pregnancy Outcomes in Women Previously Received Placental Malaria Vaccine

Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine in Papua, Indonesia

TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study

Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)

Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa

ERASE - Impact of COVID-19 on Malaria Control

Evaluating the Effects of Community Delivery of Malaria Intermittent Preventive Treatment on Pregnant Women and Babies

Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania

Assessing the Effectiveness of Community Delivery of Intermittent Preventive Treatment in Pregnancy (IPTp) in Malawi

Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya

MiMBa Pregnancy Registry

Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum

Routine Antenatal Care Versus Screening and Treatment of Malaria in Pregnancy in Rwanda

Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP)

Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance